Your browser doesn't support javascript.
loading
Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statistic.
Novick, Steven; Shen, Yan; Yang, Harry; Peterson, John; LeBlond, Dave; Altan, Stan.
Afiliação
  • Novick S; a GlaxoSmithKline Pharmaceuticals , Research Triangle Park , North Carolina , USA.
J Biopharm Stat ; 25(2): 351-71, 2015.
Article em En | MEDLINE | ID: mdl-25357203
ABSTRACT
Dissolution (or in vitro release) studies constitute an important aspect of pharmaceutical drug development. One important use of such studies is for justifying a biowaiver for post-approval changes which requires establishing equivalence between the new and old product. We propose a statistically rigorous modeling approach for this purpose based on the estimation of what we refer to as the F2 parameter, an extension of the commonly used f2 statistic. A Bayesian test procedure is proposed in relation to a set of composite hypotheses that capture the similarity requirement on the absolute mean differences between test and reference dissolution profiles. Several examples are provided to illustrate the application. Results of our simulation study comparing the performance of f2 and the proposed method show that our Bayesian approach is comparable to or in many cases superior to the f2 statistic as a decision rule. Further useful extensions of the method, such as the use of continuous-time dissolution modeling, are considered.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biofarmácia / Preparações Farmacêuticas / Modelos Estatísticos / Tecnologia Farmacêutica Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biofarmácia / Preparações Farmacêuticas / Modelos Estatísticos / Tecnologia Farmacêutica Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos